Furthermore, the inhibition of AMPK, SIRT‐1 and PGC‐1α reversed the beneficial effects of FGF19 on mitigating PA‐ and HFD‐induced lipid droplet accumulation and insulin resistance. This evidence concerns the gene PPARGC1A and Insulin resistance.